Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Before we get onto the continuing comedy at Moonpig (MOON), some good news out today for GSK (GSK) and Haleon (HLN) shareholders with some observations about the Zantac (ranitidine) litigation which has hassled both the latter two shares over the last few months.
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism
Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.